FDA Adverse Event Malfunction Summary report: N

MAVERICK²?

MDR report key: 3242960 · Received July 23, 2013

Report

Report Number
2134265-2013-05077
Event Type
Malfunction
Date Received
July 23, 2013
Date of Event
May 28, 2013
Report Date
June 24, 2013
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
LOX
PMA / PMN Number
P860019
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATED BY MFR.: RETURNED PRODUCT CONSISTED OF A MAVERICK 2 BALLOON CATHETER WITH THE SHELF BOX AND CARRIER TUBE (HOOP). THE BATCH NUMBER ON THE RETURNED DEVICE AND PACKAGING MATCHED THE REPORTED BATCH NUMBER. THERE WAS BLOOD IN THE INFLATION LUMEN AND BALLOON. THE BALLOON WAS LOOSELY FOLDED. THERE WAS A PINHOLE AND SCRATCH IN THE BALLOON WALL MATERIAL LOCATED OVER THE DISTAL MARKERBAND. INSPECTION OF THE REMAINDER OF THE DEVICE PRESENTED NO DAMAGE OR IRREGULARITIES. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL PROCEDURAL FACTORS. (B)(4).

Description of Event or Problem · 1

REPORTABLE BASED ON ANALYSIS ON (B)(4) 2013. IT WAS REPORTED THAT DURING A BALLOON ANGIOPLASTY PROCEDURE, CROSSING DIFFICULTY OCCURRED. THE TARGET LESION WAS LOCATED IN THE SEVERELY CALCIFIED MID RIGHT CORONARY ARTERY (RCA). AFTER CROSSING AN UNSPECIFIED GUIDEWIRE, A 3.75 MM X 30 MM MAVERICK BALLOON CATHETER WAS SELECTED TO CROSS THE TARGET LESION HOWEVER; THE DEVICE WAS UNABLE TO CROSS THE LESION. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO COMPLICATIONS WERE REPORTED AND PATIENT STATUS IS GOOD. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED BALLOON PINHOLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
344152 MAVERICK²? CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS LOX BOSTON SCIENTIFIC - MAPLE GROVE H7493892830370 15282899

Patients

Seq Age Sex Outcome Treatment
1